Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1016/J.SEIZURE.2017.10.007 | ||||
| Año | 2017 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Conclusions: Most patients with epilepsy had a RM, but only 61% reported receiving training. Patients were more likely to have a RM if they had prior SE and longer seizure duration. Families with a SAP were more knowledgeable, and schools were more involved. (C) 2017 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Gainza-Lein, Marina | Mujer |
Harvard Med Sch - Estados Unidos
Universidad Austral de Chile - Chile Children's Hospital Boston - Estados Unidos Boston Children's Hospital - Estados Unidos |
| 2 | Benjamin, Robert A. | Hombre |
Harvard Med Sch - Estados Unidos
Assumption Coll - Estados Unidos Children's Hospital Boston - Estados Unidos Assumption College - Estados Unidos Boston Children's Hospital - Estados Unidos Assumption University - Estados Unidos |
| 3 | Stredny, Coral M. | Mujer |
Harvard Med Sch - Estados Unidos
Children's Hospital Boston - Estados Unidos Boston Children's Hospital - Estados Unidos |
| 4 | McGurl, Marlee | Mujer |
Harvard Med Sch - Estados Unidos
Children's Hospital Boston - Estados Unidos Boston Children's Hospital - Estados Unidos |
| 5 | Kapur, K. | - |
Harvard Med Sch - Estados Unidos
Children's Hospital Boston - Estados Unidos Boston Children's Hospital - Estados Unidos |
| 6 | Loddenkemper, Tobias | Hombre |
Harvard Med Sch - Estados Unidos
Children's Hospital Boston - Estados Unidos Boston Children's Hospital - Estados Unidos |
| Fuente |
|---|
| Pediatric Epilepsy Research Foundation |
| Epilepsy Foundation of America |
| Mallinckrodt |
| Lundbeck |
| Acorda |
| Eisai |
| Epilepsy Therapy Project |
| Epilepsy Research Fund |
| Pfizer |
| American Epilepsy Society |
| CURE |
| Upsher-Smith |
| Epilepsy Foundation |
| Lundbeckfonden |
| CURE Childhood Cancer |
| Agradecimiento |
|---|
| Marina Gainza-Lein has received research support from the Epilepsy Research Fund. Tobias Loddenkemper serves on the Laboratory Accreditation Board for Long Term (Epilepsy and Intensive Care Unit) Monitoring, on the Council (and as Vice President) of the American Clinical Neurophysiology Society, on the American Board of Clinical Neurophysiology, as an Associate Editor for Seizure, and as an Associate Editor for Wyllie's Treatment of Epilepsy 6th edition. He is part of pending patent applications to detect and predict seizures and to diagnose epilepsy. He receives research support from the Epilepsy Research Fund, the American Epilepsy Society, the Epilepsy Foundation of America, the Epilepsy Therapy Project, the Pediatric Epilepsy Research Foundation,CURE and received research grants from Lundbeck, Eisai, Upsher-Smith, Acorda, Mallinckrodt, and Pfizer. He serves as a consultant for Zogenix, Upsher Smith, Sunovion, Engage, Eisai and Lundbeck. He performs video electroencephalogram long-term and ICU monitoring, electroencephalograms, and other electrophysiological studies at Boston Children's Hospital and affiliated hospitals and bills for these procedures and he evaluates pediatric neurology patients and bills for clinical care. He has received speaker honorariums from national societies including the AAN, AES and ACNS, and for grand rounds at various academic centers. His wife, Dr. Karen Stannard, is a pediatric neurologist and she performs video electroencephalogram long-term and ICU monitoring, electroencephalograms, and other electrophysiological studies and bills for these procedures and she evaluates pediatric neurology patients and bills for clinical care. |
| We thank the families who participated in this study. Marina Gaínza-Lein has received research support from the Epilepsy Research Fund . Tobias Loddenkemper serves on the Laboratory Accreditation Board for Long Term (Epilepsy and Intensive Care Unit) Monitoring, on the Council (and as Vice President) of the American Clinical Neurophysiology Society, on the American Board of Clinical Neurophysiology, as an Associate Editor for Seizure, and as an Associate Editor for Wyllie’s Treatment of Epilepsy 6th edition. He is part of pending patent applications to detect and predict seizures and to diagnose epilepsy. He receives research support from the Epilepsy Research Fund , the American Epilepsy Society , the Epilepsy Foundation of America , the Epilepsy Therapy Project , the Pediatric Epilepsy Research Foundation , CURE and received research grants from Lundbeck, Eisai, Upsher-Smith, Acorda, Mallinckrodt, and Pfizer. He serves as a consultant for Zogenix, Upsher Smith, Sunovion, Engage, Eisai and Lundbeck. He performs video electroencephalogram long-term and ICU monitoring, electroencephalograms, and other electrophysiological studies at Boston Children's Hospital and affiliated hospitals and bills for these procedures and he evaluates pediatric neurology patients and bills for clinical care. He has received speaker honorariums from national societies including the AAN, AES and ACNS, and for grand rounds at various academic centers. His wife, Dr. Karen Stannard, is a pediatric neurologist and she performs video electroencephalogram long-term and ICU monitoring, electroencephalograms, and other electrophysiological studies and bills for these procedures and she evaluates pediatric neurology patients and bills for clinical care. |